Human methylome studies SRP473783 Track Settings
 
scNanoSeq-CUT&Tag: a long-read single-cell CUT&Tag sequencing method for efficient chromatin modification profiling within individual cells [Blood]

Track collection: Human methylome studies

+  All tracks in this collection (463)

Maximum display mode:       Reset to defaults   
Select views (Help):
PMD       CpG reads ▾       AMR       CpG methylation ▾      
Select subtracks by views and experiment:
 All views PMD  CpG reads  AMR  CpG methylation 
experiment
SRX22759272 
SRX22759273 
SRX22759274 
SRX22759275 
SRX22759277 
SRX22759278 
List subtracks: only selected/visible    all    ()
  experiment↓1 views↓2   Track Name↓3  
hide
 SRX22759272  PMD  Blood / SRX22759272 (PMD)   Schema 
hide
 Configure
 SRX22759272  CpG reads  Blood / SRX22759272 (CpG reads)   Schema 
hide
 SRX22759272  AMR  Blood / SRX22759272 (AMR)   Schema 
hide
 Configure
 SRX22759272  CpG methylation  Blood / SRX22759272 (CpG methylation)   Schema 
hide
 SRX22759273  PMD  Blood / SRX22759273 (PMD)   Schema 
hide
 Configure
 SRX22759273  CpG reads  Blood / SRX22759273 (CpG reads)   Schema 
hide
 SRX22759273  AMR  Blood / SRX22759273 (AMR)   Schema 
hide
 Configure
 SRX22759273  CpG methylation  Blood / SRX22759273 (CpG methylation)   Schema 
hide
 SRX22759274  PMD  Blood / SRX22759274 (PMD)   Schema 
hide
 Configure
 SRX22759274  CpG reads  Blood / SRX22759274 (CpG reads)   Schema 
hide
 SRX22759274  AMR  Blood / SRX22759274 (AMR)   Schema 
hide
 Configure
 SRX22759274  CpG methylation  Blood / SRX22759274 (CpG methylation)   Schema 
hide
 SRX22759275  PMD  Blood / SRX22759275 (PMD)   Schema 
hide
 SRX22759275  AMR  Blood / SRX22759275 (AMR)   Schema 
hide
 Configure
 SRX22759275  CpG methylation  Blood / SRX22759275 (CpG methylation)   Schema 
hide
 Configure
 SRX22759275  CpG reads  Blood / SRX22759275 (CpG reads)   Schema 
hide
 SRX22759277  PMD  Blood / SRX22759277 (PMD)   Schema 
hide
 Configure
 SRX22759277  CpG reads  Blood / SRX22759277 (CpG reads)   Schema 
hide
 SRX22759277  AMR  Blood / SRX22759277 (AMR)   Schema 
hide
 Configure
 SRX22759277  CpG methylation  Blood / SRX22759277 (CpG methylation)   Schema 
hide
 SRX22759278  PMD  Blood / SRX22759278 (PMD)   Schema 
hide
 Configure
 SRX22759278  CpG reads  Blood / SRX22759278 (CpG reads)   Schema 
hide
 SRX22759278  AMR  Blood / SRX22759278 (AMR)   Schema 
hide
 Configure
 SRX22759278  CpG methylation  Blood / SRX22759278 (CpG methylation)   Schema 
    

Study title: scNanoSeq-CUT&Tag: a long-read single-cell CUT&Tag sequencing method for efficient chromatin modification profiling within individual cells
SRA: SRP473783
GEO: not found
Pubmed: not found

Experiment Label Methylation Coverage HMRs HMR size AMRs AMR size PMDs PMD size Conversion Details
SRX22759272 Blood 0.175 1.8 162 174280.5 64 1062.5 2557 663929.1 0.996 title: WGBS of Homo sapiensK562_drug_treatment; {"isolate": "K562 cell line", "age": "53-year-old", "biomaterial_provider": "tanglab_PKU", "collection_date": "2022-11", "geo_loc_name": "China: Beijing", "sex": "female", "tissue": "blood", "cell_line": "K562", "cell_type": "lymphoblast", "treatment": "5AZA(DNA methyltransferase inhibitors);DMSO(control)"}
SRX22759273 Blood 0.181 1.8 397 152790.2 52 1022.2 2558 663260.9 0.996 title: WGBS of Homo sapiensK562_drug_treatment; {"isolate": "K562 cell line", "age": "53-year-old", "biomaterial_provider": "tanglab_PKU", "collection_date": "2022-11", "geo_loc_name": "China: Beijing", "sex": "female", "tissue": "blood", "cell_line": "K562", "cell_type": "lymphoblast", "treatment": "5AZA(DNA methyltransferase inhibitors);DMSO(control)"}
SRX22759274 Blood 0.207 1.7 716 113912.1 38 1021.5 2565 660892.8 0.996 title: WGBS of Homo sapiensK562_drug_treatment; {"isolate": "K562 cell line", "age": "53-year-old", "biomaterial_provider": "tanglab_PKU", "collection_date": "2022-11", "geo_loc_name": "China: Beijing", "sex": "female", "tissue": "blood", "cell_line": "K562", "cell_type": "lymphoblast", "treatment": "5AZA(DNA methyltransferase inhibitors);DMSO(control)"}
SRX22759275 Blood 0.255 2.1 8841 55805.3 39 1303.9 2778 610616.2 0.996 title: WGBS of Homo sapiensK562_drug_treatment; {"isolate": "K562 cell line", "age": "53-year-old", "biomaterial_provider": "tanglab_PKU", "collection_date": "2022-11", "geo_loc_name": "China: Beijing", "sex": "female", "tissue": "blood", "cell_line": "K562", "cell_type": "lymphoblast", "treatment": "5AZA(DNA methyltransferase inhibitors);DMSO(control)"}
SRX22759277 Blood 0.259 2.1 10212 52800.1 37 1105.5 2768 610202.1 0.996 title: WGBS of Homo sapiensK562_drug_treatment; {"isolate": "K562 cell line", "age": "53-year-old", "biomaterial_provider": "tanglab_PKU", "collection_date": "2022-11", "geo_loc_name": "China: Beijing", "sex": "female", "tissue": "blood", "cell_line": "K562", "cell_type": "lymphoblast", "treatment": "5AZA(DNA methyltransferase inhibitors);DMSO(control)"}
SRX22759278 Blood 0.258 2.4 15833 47749.2 50 1033.5 2963 571999.3 0.996 title: WGBS of Homo sapiensK562_drug_treatment; {"isolate": "K562 cell line", "age": "53-year-old", "biomaterial_provider": "tanglab_PKU", "collection_date": "2022-11", "geo_loc_name": "China: Beijing", "sex": "female", "tissue": "blood", "cell_line": "K562", "cell_type": "lymphoblast", "treatment": "5AZA(DNA methyltransferase inhibitors);DMSO(control)"}

Methods

All analysis was done using a bisulfite sequnecing data analysis pipeline DNMTools developed in the Smith lab at USC.

Mapping reads from bisulfite sequencing: Bisulfite treated reads are mapped to the genomes with the abismal program. Input reads are filtered by their quality, and adapter sequences in the 3' end of reads are trimmed. This is done with cutadapt. Uniquely mapped reads with mismatches/indels below given threshold are retained. For pair-end reads, if the two mates overlap, the overlapping part of the mate with lower quality is discarded. After mapping, we use the format command in dnmtools to merge mates for paired-end reads. We use the dnmtools uniq command to randomly select one from multiple reads mapped exactly to the same location. Without random oligos as UMIs, this is our best indication of PCR duplicates.

Estimating methylation levels: After reads are mapped and filtered, the dnmtools counts command is used to obtain read coverage and estimate methylation levels at individual cytosine sites. We count the number of methylated reads (those containing a C) and the number of unmethylated reads (those containing a T) at each nucleotide in a mapped read that corresponds to a cytosine in the reference genome. The methylation level of that cytosine is estimated as the ratio of methylated to total reads covering that cytosine. For cytosines in the symmetric CpG sequence context, reads from the both strands are collapsed to give a single estimate. Very rarely do the levels differ between strands (typically only if there has been a substitution, as in a somatic mutation), and this approach gives a better estimate.

Bisulfite conversion rate: The bisulfite conversion rate for an experiment is estimated with the dnmtools bsrate command, which computes the fraction of successfully converted nucleotides in reads (those read out as Ts) among all nucleotides in the reads mapped that map over cytosines in the reference genome. This is done either using a spike-in (e.g., lambda), the mitochondrial DNA, or the nuclear genome. In the latter case, only non-CpG sites are used. While this latter approach can be impacted by non-CpG cytosine methylation, in practice it never amounts to much.

Identifying hypomethylated regions (HMRs): In most mammalian cells, the majority of the genome has high methylation, and regions of low methylation are typically the interesting features. (This seems to be true for essentially all healthy differentiated cell types, but not cells of very early embryogenesis, various germ cells and precursors, and placental lineage cells.) These are valleys of low methylation are called hypomethylated regions (HMR) for historical reasons. To identify the HMRs, we use the dnmtools hmr command, which uses a statistical model that accounts for both the methylation level fluctations and the varying amounts of data available at each CpG site.

Partially methylated domains: Partially methylated domains are large genomic regions showing partial methylation observed in immortalized cell lines and cancerous cells. The pmd program is used to identify PMDs.

Allele-specific methylation: Allele-Specific methylated regions refers to regions where the parental allele is differentially methylated compared to the maternal allele. The program allelic is used to compute allele-specific methylation score can be computed for each CpG site by testing the linkage between methylation status of adjacent reads, and the program amrfinder is used to identify regions with allele-specific methylation.

For more detailed description of the methods of each step, please refer to the DNMTools documentation.